SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001999371-23-000907
Filing Date
2023-12-08
Accepted
2023-12-08 17:14:17
Documents
13
Period of Report
2023-12-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp_8k-120823.htm   iXBRL 8-K 31448
2 LOAN AND GUARANTY AGREEMENT ex10-01.htm EX-10.01 279269
  Complete submission text file 0001999371-23-000907.txt   559613

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE tnxp-20231208.xsd EX-101.SCH 3024
4 XBRL LABEL FILE tnxp-20231208_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE tnxp-20231208_pre.xml EX-101.PRE 22365
7 EXTRACTED XBRL INSTANCE DOCUMENT tnxp_8k-120823_htm.xml XML 3191
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 231476310
SIC: 2834 Pharmaceutical Preparations